Moreover, the pRB+ fraction of CDKN2A+ cells correlated with tumor growth; M-Smo/Ezh2cKO tumors, which progressed faster than M-Smo/EedcKO tumors, showed higher pRB+ fractions of CDKN2A+ cells at P12. This evidence concerns the gene CDKN2A and neoplasm.